BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pathology News
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260119T140000
DTEND;TZID=UTC:20260119T150000
DTSTAMP:20260827T213050
CREATED:20260107T121138Z
LAST-MODIFIED:20260107T121138Z
UID:100117733-1768831200-1768834800@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series – Do androids dream of digital diagnoses? A pathologist’s perspective on digital and computational pathology.
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Diana Montezuma Felizardo from IMP Diagnostics\, Portugal. \nAbstract\nWith a nod to Do androids dream of electric sheep? this talk will explore digital and computational pathology from a pathologist’s point of view. This session aims to be very practical\, bringing together a pot pourri of insights from real-world digital deployment and hands-on experience with computational research projects. The goal is to demystify the digital transition\, highlight pathologists’ contributions to CPath projects\, and emphasise the importance of multidisciplinarity in CPath research. \nRegister NowBio\nPathologist\, currently coordinating the R&D Unit at IMP Diagnostics (Portugal); invited junior researcher at the Cancer Biology and Epigenetics Group (CBEG) – Portuguese Institute of Oncology of Porto; board member and chair of the Scientific Committee of the European Society of Digital and Integrative Pathology (ESDIP). Medical degree from University of Coimbra (FMUC); PhD in Medical Sciences from ICBAS\, University of Porto.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-do-androids-dream-of-digital-diagnoses-a-pathologists-perspective-on-digital-and-computational-pathology/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2026/01/TIA-Centre-Seminar-Series-–-Do-androids-dream-of-digital-diagnoses-A-pathologists-perspective-on-digital-and-computational-pathology.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251210T163000
DTEND;TZID=Europe/London:20251210T173000
DTSTAMP:20260827T213050
CREATED:20251126T143234Z
LAST-MODIFIED:20251126T143234Z
UID:100117131-1765384200-1765387800@www.pathologynews.com
SUMMARY:Beyond the Image: Powering the Future of Life Sciences Research with Concentriq LS
DESCRIPTION:0000Days00Hrs00Min00SecJoin Proscia as they demo the latest Concentriq LS releases\, which are designed to help research teams analyze faster\, collaborate smarter\, and stay ready for the future of image-based discovery.\nThe latest Concentriq AP releases of v4.9 in June and v4.10 in September are focused on more than just new features. They are about providing the strategic foundation that every Anatomic Pathology lab needs to succeed in a digital world: \nEnterprise-Ready Scale & Security: See how multi-LIS support\, improved user-defined fields (UDFs)\, and self-service tools like in-app API key management enable flexible\, secure growth across sites. \nAgnostic Interoperability: Discover how expanded fluorescence imaging compatibility\, enhanced image lifecycle management\, and new AI integrations empower your lab to connect all scanners\, images\, and AI tools no matter the vendor. \nPathologist-Centric Workflow Optimization: View how navigation updates bring digital pathology even closer to the microscope\, from ergonomic and inverted panning to customizable zoom and review preferences. \nWhether you’re a multi-site health system or a private lab accelerating your digital transformation\, this live session will show how Concentriq AP’s latest releases deliver the interoperability\, scalability\, and usability needed to unlock new levels of performance and productivity. \nWant a sneak peek into the latest AP updates? Read our recent blog: Multi-Site LIS\, FL Images & More: Standout Updates in the Latest Concentriq AP Releases \nRegister NowPresenters\nAnisha Mohan\nProduct Manager\, Life Sciences\n\nRitida Nanda\nSenior Product Marketing Manager\, Life Sciences
URL:https://www.pathologynews.com/event/beyond-the-image-powering-the-future-of-life-sciences-research-with-concentriq-ls/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/11/Beyond-the-Image-Powering-the-Future-of-Life-Sciences-Research-with-Concentriq-LS-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251212
DTSTAMP:20260827T213050
CREATED:20250513T103800Z
LAST-MODIFIED:20251007T103743Z
UID:100111941-1765324800-1765497599@www.pathologynews.com
SUMMARY:12th Digital Pathology & AI Congress: Europe
DESCRIPTION:0000Days00Hrs00Min00SecRegister using the link. There is also a Pathology News exclusive discount code available for this event \n\n\nThis internationally recognised meeting is the only meeting truly focused on the transformative power of Digital Pathology and the advances created by Artificial Intelligence and Machine Learning. Across the health sector and pharmaceutical/biotech industry the adoption of digital pathology is speeding up. It’s impact is being felt in primary diagnosis and clinical research  as well as the laboratory. \nRealisable benefits include:\n1. Enhanced Diagnostic Accuracy\n2. Increased Workflow Efficiency\n3. Accelerated Drug Discovery\n4. Improved Patient Outcomes\n5. Cost Savings \nNo wonder health services are implementing digital pathology to improve diagnostic services and patient outcomes particularly for better cancer diagnostics and treatment planning. While research institutions and pharmaceutical companies are leveraging AI to accelerate drug discovery and development\, leading to more innovative treatments reaching the market faster. \nIf you are just starting your digital journey\, or well down the road of harnessing the technology don’t miss this must-attend event  so you can maximize the potential of digital pathology and AI. \n\n\nRegister Now\n\n\n\n\n\n\n\nDiscount Code Available\nJoin our newsletter to receive the latest news\, promotional codes\, and much more… \n\n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n\n\n\n \n\n\nYou can unsubscribe anytime. For more details\, review our Privacy Policy. \n\n\n \n \n\nSubmit & Recieve Promo Code Via Email \n\nLoading… \n\n \n\n\n\n\nThank you!\nYou have successfully joined our subscriber list.
URL:https://www.pathologynews.com/event/12th-digital-pathology-ai-congress-europe/
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/DPAI-London-25.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251209T163000
DTEND;TZID=Europe/London:20251209T173000
DTSTAMP:20260827T213050
CREATED:20251125T120357Z
LAST-MODIFIED:20251125T120357Z
UID:100117077-1765297800-1765301400@www.pathologynews.com
SUMMARY:Scaling Smarter: Future-Proofing Pathology with Concentriq AP
DESCRIPTION:0000Days00Hrs00Min00SecJoin Proscia as they demo the latest Concentriq AP releases\, which are designed to help pathology teams scale securely\, work smarter\, and stay ready for the future of digital pathology.\nThe latest Concentriq AP releases of v4.9 in June and v4.10 in September are focused on more than just new features. They are about providing the strategic foundation that every Anatomic Pathology lab needs to succeed in a digital world: \nEnterprise-Ready Scale & Security: See how multi-LIS support\, improved user-defined fields (UDFs)\, and self-service tools like in-app API key management enable flexible\, secure growth across sites. \nAgnostic Interoperability: Discover how expanded fluorescence imaging compatibility\, enhanced image lifecycle management\, and new AI integrations empower your lab to connect all scanners\, images\, and AI tools no matter the vendor. \nPathologist-Centric Workflow Optimization: View how navigation updates bring digital pathology even closer to the microscope\, from ergonomic and inverted panning to customizable zoom and review preferences. \nWhether you’re a multi-site health system or a private lab accelerating your digital transformation\, this live session will show how Concentriq AP’s latest releases deliver the interoperability\, scalability\, and usability needed to unlock new levels of performance and productivity. \nWant a sneak peek into the latest AP updates? Read our recent blog: Multi-Site LIS\, FL Images & More: Standout Updates in the Latest Concentriq AP Releases \nRegister NowPresenter\nAmanda Coble\nSenior Director of Product
URL:https://www.pathologynews.com/event/scaling-smarter-future-proofing-pathology-with-concentriq-ap/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/11/Scaling-Smarter-Future-Proofing-Pathology-with-Concentriq-AP.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251209
DTEND;VALUE=DATE:20251211
DTSTAMP:20260827T213050
CREATED:20250820T092147Z
LAST-MODIFIED:20250821T092553Z
UID:100115165-1765238400-1765411199@www.pathologynews.com
SUMMARY:Introduction to DICOM in Digital Pathology
DESCRIPTION:0000Days00Hrs00Min00SecPlan ahead to attend Introduction to DICOM in Digital Pathology\, a 2-day training\, delivered virtually through Zoom on Dec 9-10. (member rates available!) This hands-on training program provides an in-depth understanding of DICOM in digital pathology\, covering metadata\, image encoding\, storage solutions\, interoperability challenges\, and future trends. \nDigital pathology is rapidly evolving\, and DICOM (Digital Imaging and Communications in Medicine) is the key standard for interoperability and storage. This two-day hands-on training program provides an in-depth understanding of DICOM in digital pathology\, covering metadata\, image encoding\, storage solutions\, interoperability challenges\, and future trends. Participants will explore real-world applications through interactive exercises\, discussions\, and practical demonstrations. By the end of the course\, attendees will have the knowledge and skills to implement DICOM workflows in pathology environments\, improving data integration\, accessibility\, and compliance. Development of this course includes input from pathologists with first-hand experience in implementing DICOM in their current practices\, giving you a real-world perspective. \nLearning Objectives\nBy the end of this course\, participants will be able to: \n\nExplain the role of DICOM in digital pathology and how it differs from radiology applications.\nIdentify key metadata structures\, file formats\, and pixel data encoding relevant to pathology imaging.\nImplement and test DICOM Associations in combination with Storage/Storage Commitment.\nImplement and test DICOMweb APIs (WADO\, QIDO) for querying and retrieving pathology images.\nDesign and evaluate storage solutions\, including Vendor Neutral Archives (VNAs) for pathology labs.\nUtilize DICOM converters to transform pathology images and ensure interoperability with PACS.\nRecognize legal\, IT\, and standardization challenges in implementing DICOM-based pathology workflows.\nDiscuss how AI\, machine learning\, and emerging technologies are shaping the future of digital pathology.\n\nRegister NowFormat/Class Structure\nThis 2-day training will be delivered virtual live through Zoom on September 8th and 9th. Training on both days will start at 11:00am and end at 4:30 pm ET. There will be one 15-minute and one 30-minute break each day. \nWho Should Take This Course\nThis course is designed for: \n\nPathologists & Laboratory Technicians\nHealthcare IT Professionals & PACS Administrators\nMedical Imaging & Informatics Specialists\nSoftware Developers & Engineers in Digital Pathology\nRegulatory & Compliance Officers
URL:https://www.pathologynews.com/event/introduction-to-dicom-in-digital-pathology/
LOCATION:Online
CATEGORIES:Online Training
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/Introduction-to-DICOM-in-Digital-Pathology.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251208T140000
DTEND;TZID=Europe/London:20251208T150000
DTSTAMP:20260827T213050
CREATED:20251126T120420Z
LAST-MODIFIED:20251126T120420Z
UID:100117143-1765202400-1765206000@www.pathologynews.com
SUMMARY:The DIAGGRAFT project - Developing AI for kidney transplant diagnostics
DESCRIPTION:0000Days00Hrs00Min00SecThe Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Linda Studer from Radboud UMC\, Nijmegen\, The Netherlands. \nAbstract\nGiven the significant increase in kidney transplantations\, maximizing long-term transplant survival is even more important. While histopathologic assessment of biopsies remains the diagnostic gold standard\, the current diagnostic classification system (Banff Lesion Scores) possesses considerable observer variability\, is mostly qualitative\, and lacks granularity in key areas\, therefore challenging biopsy assessment. To address these limitations\, the DIAGGRAFT project aims to develop and clinically validate deep learning-based tools for renal transplant histopathology. The first step of the project was the development of tissue segmentation algorithms for the key renal compartments. The second step focused on automating the objective quantification of inflammatory cells necessary for reproducible Banff scoring\, for which we launched the MONKEY (Machine-learning for Optimal detection of iNflammatory cells in the KidnEY) computational challenge. Currently\, we are running a validation study with over 40 pathologists to assess the clinical utility\, efficiency\, and integration readiness of these algorithms. \nRegister NowBio\nLinda Studer holds a PhD in Computer Science from the University of Fribourg\, Switzerland\, and has an academic background in life sciences. Her PhD mainly focused on the use of Graph Neural Networks for colorectal cancer histopathology. Currently\, she is a Postdoctoral Researcher within the Computational Pathology Group (CPG) at Radboudumc. She is working on the DIAGGRAFT project\, which focuses on developing AI solutions for kidney transplant diagnostics. As part of this project\, she led the MONKEY computational challenge (a MIDL 2025 challenge)\, which focused on the detection and classification of inflammatory cells in PAS-stained kidney transplant biopsies. She was also an organizer for the COMPAYL workshop at MICCAI 2024 and 2025.
URL:https://www.pathologynews.com/event/the-diaggraft-project-developing-ai-for-kidney-transplant-diagnostics/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/11/TIA-Centre-Seminar-Series-–-The-DIAGGRAFT-project-Developing-AI-for-kidney-transplant-diagnostics.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251203
DTEND;VALUE=DATE:20251205
DTSTAMP:20260827T213050
CREATED:20250711T145007Z
LAST-MODIFIED:20250731T142519Z
UID:100114341-1764720000-1764892799@www.pathologynews.com
SUMMARY:EPIC Technology Meeting on Cancer Pathology\, Therapy and Surgery at Gustave Roussy
DESCRIPTION:0000Days00Hrs00Min00SecPhotonics technologies have shown great promise in advancing both the diagnosis and therapy of cancer\, offering highly precise\, non-invasive and\, in some cases\, real-time solutions. Techniques such as optical coherence tomography (OCT)\, fluorescence imaging\, and Raman spectroscopy enable early detection and detailed imaging of tumors at a cellular level. Their goal is to overcome some of the disadvantages of the traditional methods in terms of accuracy and speed of the diagnosis. Novel imaging techniques can also offer new advantages in intraoperative margin assessment in surgical oncology. For cancer therapy\, photonics plays a critical role in approaches like photodynamic therapy\, where light is used to activate photosensitive drugs that selectively target and destroy cancer cells. And laser sources can be used on surgical applications due to their capability to destroy tumors with minimal damage to surrounding healthy tissue. The integration of photonics with molecular imaging and targeted drug delivery systems is also enhancing the precision of cancer treatments\, improving outcomes\, and minimizing side effects. \nThis meeting will bring together medical doctors from different departments to discuss with the photonics community the actual status of the solutions they use and the remaining challenges and needs. From this discussion\, integrators\, manufacturing of complete systems and components manufacturers will understand the way to improve their developments to address the specific problems of the medical community. In order to support companies in this challenging process\, a specific session on regulations\, certifications and hospital management needs will be organized to have new recommendations and advice from experts in these topics. \nRegister NowMeet Our Partner
URL:https://www.pathologynews.com/event/epic-technology-meeting-on-cancer-pathology-therapy-and-surgery-at-gustave-roussy/
LOCATION:Gustave Roussy Cancer Campus\, Paris\, France
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/07/EPIC-Technology-Meeting-on-Cancer-Pathology-Therapy-and-Surgery-at-Gustave-Roussy.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251202T140000
DTEND;TZID=Europe/London:20251202T150000
DTSTAMP:20260827T213050
CREATED:20251021T100345Z
LAST-MODIFIED:20251021T100412Z
UID:100116308-1764684000-1764687600@www.pathologynews.com
SUMMARY:Navigating the Future: Implementing Digital Pathology
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 2 PM GMT\, 3 PM CET\, and 9 AM EST. \nJoin us for an insightful conversation on what it truly takes to implement a successful\, scalable digital pathology service. \nIn this webinar\, Christopher Parry\, Digital Pathology Sales Specialist at Roche\, and Paul Flavell\, Programme and Portfolio Manager\, draw on their combined expertise in cellular pathology\, cloud migration\, and digital transformation to explore the journey from vision to implementation. \nThrough a presentation and conversational Q&A format\, they’ll unpack the key stages of digital adoption from defining why digitisation matters\, to managing integration\, networking\, and storage requirements\, and overcoming real-world challenges through strong partnerships and collaboration. \nLearning Objectives\n\nWhy a network-wide digital pathology service requires more than just hardware.\nHow strong relationships have driven successful digital pathology deployment.\nWhat benefits are already being realised and what the future holds as AI and algorithmic tools become part of routine diagnosis.\n\nRegister NowPresenters\nChristopher Parry \nWith over 10 years experience within Cellular Pathology\, Chris is now a Digital Pathology Sales Specialist at Roche\, Chris is passionate about leveraging digital pathology and AI to transform cellular pathology. With a focus on driving diagnostic certainty and alleviating the significant backlogs within the field. Background includes roles in tissue diagnostics sales\, as an applications consultant\, and as a biomedical scientist in both the NHS and private sectors. \nPaul Flavell \nPaul is a highly experienced Programme and Portfolio manager\, delivering large complex data center migrations\, cloud migrations and cloud optimisation programmes of work across multiple industries sectors. 5 years with Roche leading teams to design and deliver digital solutions.
URL:https://www.pathologynews.com/event/navigating-the-future-implementing-digital-pathology/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/ROC-WEB0-Featured-image-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251126T140000
DTEND;TZID=Europe/London:20251126T150000
DTSTAMP:20260827T213050
CREATED:20251112T171912Z
LAST-MODIFIED:20251112T171912Z
UID:100116779-1764165600-1764169200@www.pathologynews.com
SUMMARY:Optimizing the pathology workflow with Aiforia® Breast Cancer Suite
DESCRIPTION:Join Aiforia to learn how AI technology can enhance precision\, speed\, and diagnostic accuracy in breast cancer diagnostics. \nPathologist and Aiforia’s Medical Director\, Richard Doughty\, will discuss his experiences working with breast cancer tissue samples in routine diagnostics. He will showcase a typical BC workflow with and without AI and explain how Aiforia’s AI seamlessly integrates to enhance every step\, from sample analysis to diagnosis. \nAiforia®️ Breast Cancer Suite is the most comprehensive AI toolkit for breast cancer diagnostics\, supporting the entire diagnostic workflow. It consists of six CE-IVD marked AI solutions with an optimized interactive user interface that assists pathologists in the histological grading of breast cancer\, assessment of breast cancer IHC markers\, and the detection of lymph node metastasis. The user can review\, verify\, and modify results\, ensuring the highest quality of output. \nWho should join?\n\nPathologists involved in the routine diagnostic workflow for breast cancer\nOncologists and other clinicians who rely on accurate and timely breast cancer diagnostics for treatment planning\nLaboratory directors and administrators interested in implementing AI-powered digital pathology tools to improve efficiency and precision\nAnyone involved in breast cancer diagnostics who wants to learn about the practical application of AI in histological grading\, IHC marker assessment\, and metastasis detection\n\nRegister NowSpeakers\nRichard Doughty\, DVM\, MD\, MSc\nMedical Director at Aiforia Technologies \n\nConsulting pathologist at Oslo University Hospital\nMedical doctor and specialist in pathology with extensive diagnostic experience.\nQualified veterinarian with pathology expertise in pharmaceutical research and development.\n\nRute Pedrosa\, PhD\nSenior Field Application Scientist\, Aiforia Technologies \n\nHas worked at Aiforia for 2.5 years\nPhD at Erasmus University Rotterdam\, focusing on the pathogenesis of brain metastatic disease
URL:https://www.pathologynews.com/event/optimizing-the-pathology-workflow-with-aiforia-breast-cancer-suite/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/11/Optimizing-the-pathology-workflow-with-Aiforia®-Breast-Cancer-Suite.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251125T150000
DTEND;TZID=Europe/London:20251125T160000
DTSTAMP:20260827T213050
CREATED:20251106T111722Z
LAST-MODIFIED:20251106T111723Z
UID:100116685-1764082800-1764086400@www.pathologynews.com
SUMMARY:AI in Clinical Digital Pathology: An introduction and live demonstrations of Aperio HALO AP and Aperio AI Store
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 4 PM CET\, 3 PM GMT\, and 10 AM EST. \nJoin Leica Biosystems for a dynamic one-hour session exploring how cutting-edge software and artificial intelligence are transforming clinical digital pathology. This webinar will showcase live demonstrations of the Aperio HALO AP Image Management Solution and Aperio AI Store. \n\nBuilding Now for Tomorrow’s Future: Rob Monroe\, MD\, PhD\, VP & Chief Scientific Officer\, Oncology\, Danaher Diagnostics\, Chief Medical Officer\, Leica Biosystems\nIntroduction and Demonstrations for Aperio HALO AP and Aperio AI Store: Bryce Brown\, Director\, Product Management\, Leica Biosystems\nLive Audience Q & A: Linda Fildey\, Senior Manager\, Global Customer Advocacy\, Leica Biosystems (attendees are invited to participate in a live Q&A session with our experts to dive deeper into the technologies and innovations discussed).\n\nWebinar learning objectives:\n\nDiscover how AI tools are empowering pathologists and histotechnologists with advanced tools to enhance diagnostic precision\, streamline workflows\, and support better patient outcomes.\nExplore the capabilities of Aperio HALO AP and Aperio AI Store through live demonstrations\, highlighting practical applications in real-world pathology settings.\nPractical considerations on the importance of building future-ready digital pathology infrastructure\n\nRegister NowPresenters\nRob Monroe\, MD\, PhD\, VP & Chief Scientific Officer\, Oncology\, Danaher Diagnostics\, Chief Medical Officer\, Leica Biosystems \nRob joined Danaher in January 2022 to help drive oncology initiatives for the Diagnostics Platform and lead Medical Affairs at Leica Biosystems. Over the course of his career\, Rob has served in multiple Chief Medical Officer and Medical Director roles for diagnostics companies including Bio-Techne\, Advanced Cell Diagnostics\, Veracyte\, and BioImagene. Before joining industry\, Rob practiced pathology in the Central Coast of California following residency/fellowship training in Pathology at UCLA and Stanford and MD/PhD training at Harvard Medical School. \nBryce Brown\, Director\, Product Management\, Leica Biosystems \nBryce Brown is an accomplished leader in digital pathology and molecular diagnostics\, currently serving as Director of Product Management\, Digital Pathology at Leica Biosystems. With over a decade of experience at Leica Biosystems\, Bryce has held multiple strategic roles\, including leadership in Artificial Intelligence and Machine Learning\, where he helped shape product innovation across remote teams in the U.S.. Bryce has also worked as a Cytogenetic Hematological Chromosome Technologist at the Mayo Clinic\, where he contributed to high-impact clinical diagnostics in hematological disorders. He holds a Bachelor of Science in Cellular and Molecular Biology from Winona State University. \nLinda Fildey\nSenior Manager\, Global Customer Advocacy\nLeica Biosystems
URL:https://www.pathologynews.com/event/ai-in-clinical-digital-pathology-an-introduction-and-live-demonstrations-of-aperio-halo-ap-and-aperio-ai-store/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/11/FINAL-LSB-WEB8-800X600.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251121T110000
DTEND;TZID=Europe/London:20251121T120000
DTSTAMP:20260827T213050
CREATED:20251103T163125Z
LAST-MODIFIED:20251103T163125Z
UID:100116619-1763722800-1763726400@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series - Pathology knowledge-guided AI models in computational pathology
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Professor Jin Tae Kwak from Korea University\, Seoul\, South Korea. \nAbstract\nComputational pathology is undergoing a profound transformation driven large-scale artificial intelligence (AI)\, particularly the seamless integration of multiple data modalities through multimodal large language models (MLLMs). In this talk\, I will present our group’s recent efforts in developing knowledge-guided computational pathology tools that utilize vision-language models for various diagnostic tasks. I will discuss how vision-language models\, combined with expert knowledge\, can aid in analyzing complex tissue patterns\, enhancing interpretability\, and achieving accurate and reliable diagnostic performance. \nRegister NowBio\nJin Tae Kwak received his Ph.D. in Computer Science from University of Illinois at Urbana-Champaign\, USA in 2012. He earned his Masters of Science degree in Electrical and Computer Engineering from Purdue University\, USA in 2007 and his Bachelor of Engineering degree in Electrical Engineering from Korea University\, Korea in 2005. In 2012\, He joined Center for Interventional Oncology\, Clinical Center\, National Institutes of Health\, USA as a Research Fellow. He served as a tenure-track faculty member in the department of Computer Science and Engineering at Sejong University from March 2016 to August 2020. He joined School of Electrical Engineering at Korea University in September 2020. His research interests include multimodal medical imaging\, digital and computational pathology\, and large-scale and efficient AI systems for medicine
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-pathology-knowledge-guided-ai-models-in-computational-pathology/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/11/TIA-Centre-Seminar-Series-–-Pathology-knowledge-guided-AI-models-in-computational-pathology.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251120T160000
DTEND;TZID=Europe/London:20251120T170000
DTSTAMP:20260827T213050
CREATED:20251009T090234Z
LAST-MODIFIED:20251009T090234Z
UID:100115983-1763654400-1763658000@www.pathologynews.com
SUMMARY:HistoWiz x PathologyOutlines: Seamless Digital Slide Integration with PathologyMap™
DESCRIPTION:0000Days00Hrs00Min00SecJoin HistoWiz and PathologyOutlines.com for an inside look at how their new partnership is transforming digital pathology publishing. This webinar will showcase how PathologyMap™\, HistoWiz’s secure digital slide management platform\, now integrates with PathologyOutlines.com to make research articles more interactive and accessible. Attendees will see firsthand how authors can easily upload digital slides\, embed high-resolution images directly into articles\, and provide readers with frictionless access to pathology content. Learn how this collaboration is setting a new standard for open-access education and discover tools that simplify workflows for authors\, readers\, and the pathology community at large. \nLearning Objectives\n\nUnderstand how PathologyMap™ integrates with PathologyOutlines.com to simplify digital slide sharing and publishing.\nIdentify the benefits of embedding interactive whole slide images within research articles for both authors and readers.\nExplore how this collaboration supports open-access education and democratizes access to pathology data worldwide.\nRecognize opportunities to adopt digital pathology tools that enhance learning\, research dissemination\, and clinical insights.\n\nRegister NowSpeakers\nAkash Parvatikar\, PhD \nAI Scientist and Product Manager\, HistoWiz \nKristi Marie \nManaging Editor\, PathologyOutlines.com
URL:https://www.pathologynews.com/event/histowiz-x-pathologyoutlines-seamless-digital-slide-integration-with-pathologymap/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/Histowiz-webinar-featured-image.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251119
DTEND;VALUE=DATE:20251122
DTSTAMP:20260827T213050
CREATED:20251014T140535Z
LAST-MODIFIED:20251014T140535Z
UID:100116192-1763510400-1763769599@www.pathologynews.com
SUMMARY:Carrefour Pathologie 2025
DESCRIPTION:The congress took place in a beautifully rehabilitated venue\, designed to meet expectations and widely appreciated by participants. The 2024 edition was a great success\, bringing together 1\,486 participants (a record!) and receiving excellent feedback from both pathologists and exhibitors. \nCARREFOUR 2025 will once again bring together professionals in Pathological Anatomy and Cytology for a unique moment of learning\, exchange\, and collaboration. The event will be held in person\, with all sessions available afterwards as podcasts for registered participants via the Carrefour media library. \nRegister NowKey Features of CARREFOUR 2025\nScientific Programme designed by Professor Séverine Valmary-Dégano and the scientific committee. \nHistoseminars on: \n\nColorectal tumors\nThyroid pathology\nOvarian pathology\n\nConferences by world-renowned French and international pathologists covering: \n\nFrance Genomics 2025 program\nEthics and artificial intelligence\nPulmonary cytology and mediastinal pathology\n\nSymposia Topics \n\nTheranostic markers\nEcological transition and quality\nBilio-pancreatic cytology\nFeto-placental pathology\nOrgan transplant rejection\n\nInteractive Session \n\nFocused on the management of prostate biopsies — one of the most anticipated sessions of the event\n\nAIP Day (Friday) \n\nTheme: Pulmonary Tumor and Pseudotumoral Pathology\n\nMedico-Technical Sessions \n\nThe Macroscopic Technician: Crossed Views and Feedback\nThe Cyber-ACP Attack: Action / Reaction / Anticipation
URL:https://www.pathologynews.com/event/carrefour-pathologie-2025/
LOCATION:CNIT Forest in Paris la Défense\, 2 Le PARV de la Défense\, Paris\, 92800\, France
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/Carrefour-Pathologie-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251117T140000
DTEND;TZID=Europe/London:20251117T150000
DTSTAMP:20260827T213050
CREATED:20251111T142519Z
LAST-MODIFIED:20251111T142519Z
UID:100116750-1763388000-1763391600@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series – Too Many Models\, Too Few Benchmarks: Addressing the benchmarking crisis in AI for pathology
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Professor Jana Lipkova from the University of California\, Irvine\, USA. \nAbstract\nThe field of AI in pathology is experiencing a benchmarking crisis. New models emerge weekly\, each claiming superiority over predecessors\, yet the community lacks rigorous\, reproducible tools to validate these claims. In this talk\, I will present two open benchmarks from our group to address this gap. The first benchmark systematically evaluates state-of-the-art pathology foundation models (FMs) for survival prediction in oncology. We assess model generalization across multiple external cohorts\, compare architectural paradigms (patch- vs. slide-level\, uni- vs. multimodal)\, probe model interpretability and investigate weather FM allow to build pan-cancer generalists model that replace disease-specific models and generalize to rare cancers and conditions not seen during the model training? The second benchmark introduces a framework for safe AI deployment in pathology\, focusing on out-of-distribution (OOD) detection and model “guardrails.” We propose a new taxonomy for OOD scenarios in pathology and a public benchmark that stress-tests existing OOD models across diverse data shifts and real-world variability. Both benchmarks\, including all datasets\, standardized splits\, and evaluation protocols\, are publicly released to serve as standards for model evaluation and comparison\, thereby accelerate further advances and deployment of AI in pathology. \nRegister NowBio\nJana is an Assistant Professor at the University of California\, Irvine\, with joint appointments in the School of Medicine\, School of Biomedical Engineering\, and the School of Computer Science. She completed her postdoctoral fellowship in the AI for Pathology group at Harvard Medical School\, under the mentorship of Dr. Faisal Mahmood. Prior to that\, she earned her Ph.D. in computer-aided medical procedures from the Department of Radiology at the Technical University of Munich. Jana leads the OctoPath Lab (http://octopath.org/)\, which develops AI methods for diagnosis\, prognosis\, and treatment optimization in histopathology and beyond.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-too-many-models-too-few-benchmarks-addressing-the-benchmarking-crisis-in-ai-for-pathology/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/11/TIA-Centre-Seminar-Series-–-Too-Many-Models-Too-Few-Benchmarks-Addressing-the-benchmarking-crisis-in-AI-for-pathology-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251113T160000
DTEND;TZID=Europe/London:20251113T170000
DTSTAMP:20260827T213050
CREATED:20251013T142900Z
LAST-MODIFIED:20251022T123244Z
UID:100116156-1763049600-1763053200@www.pathologynews.com
SUMMARY:Mastering Image Quality Control with AIRA Matrix
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 5 PM CET\, 4 PM GMT\, and 11 AM EST. \nArtificial intelligence is transforming how laboratories and life science organizations approach quality control. This webinar will answer the key question: Why address quality control issues with AI? We’ll explore the benefits of AI-driven solutions\, highlight differentiating features\, and provide a live product demonstration to show how Aira Matrix can improve efficiency and consistency in lab workflows. Attendees will gain practical insights into how AI can help reduce errors\, streamline processes\, and support more reliable outcomes. \nThe session will be led by Marco Comianos\, who heads Aira Matrix’s commercial organization in the United States and Canada. With over 25 years of experience in sales\, marketing\, and commercial leadership across healthcare and life sciences—including roles in medical imaging\, EMR\, and healthcare AI—Marco brings deep expertise in aligning innovative technologies with real-world clinical and research needs. \nLearning Objectives\n\nWhy addressing quality control with AI matters\nHow Aira Matrix differentiates itself in the market\nKey product features and their impact on efficiency\nA live demo of the platform in action\n\nRegister NowPresenter\nMarco Comianos heads Aira Matrix’s commercial organization in the United States and Canada.  He has over 25 years of experience in sales\, marketing and commercial leadership in the Healthcare and Life Sciences industries\, at a broad range of medical imaging\, EMR and healthcare AI companies. He holds a Bachelor of Science Degree in Business Administration
URL:https://www.pathologynews.com/event/mastering-image-quality-control-with-aira-matrix-2/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/AIM-WEB0-Featured-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251111
DTEND;VALUE=DATE:20251116
DTSTAMP:20260827T213050
CREATED:20250625T105457Z
LAST-MODIFIED:20250625T105457Z
UID:100113804-1762819200-1763251199@www.pathologynews.com
SUMMARY:AMP 2025 Annual Meeting & Expo
DESCRIPTION:0000Days00Hrs00Min00SecJoin leading experts in molecular diagnostics at the AMP 2025 Annual Meeting & Expo\, the premier event hosted by the Association for Molecular Pathology. This international gathering offers cutting-edge insights\, hands-on workshops\, and a dynamic expo showcasing the latest innovations in precision medicine and clinical genomics. \nKey topic areas include:\n\nGenetics\nHematopathology\nInfectious Diseases\nInformatics\nSolid Tumors\nTechnical Topics\nEducation & Emerging Areas\n\nWhether you’re advancing laboratory practices\, exploring new technologies\, or shaping the future of molecular medicine\, AMP 2025 is the place to connect\, learn\, and lead. \nRegister Now
URL:https://www.pathologynews.com/event/amp-2025-annual-meeting-expo/
LOCATION:Boston Convention and Exhibition Center\, Boston\, MA\, United States
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/06/AMP-2025-Annual-Meeting-Expo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251110T140000
DTEND;TZID=Europe/London:20251110T150000
DTSTAMP:20260827T213050
CREATED:20251029T090353Z
LAST-MODIFIED:20251029T090353Z
UID:100116469-1762783200-1762786800@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series - Scaling Multiplexed Protein Imaging Analysis for Subcellular-resolution Pathology
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Malte Kuehl from Aarhus University\, Denmark. \nAbstract\nProteins and their spatial distribution constitute the functional foundation of biology\, offering critical insights into health and disease. However\, probing pathological tissues at subcellular resolution remains challenging\, from experimental design through image acquisition to computational analysis. I will present our recent work on Pathology-oriented multiPlexing (PathoPlex) published in Nature\, which introduces key innovations spanning quality control\, experimental design\, and image acquisition\, alongside spatiomic\, a novel software library that accelerates spatial proteomics analysis at the pixel level and beyond. Finally\, I will discuss how these developments\, combined with advances in spatial statistics\, agentic AI\, and collaborative community efforts in open-source software\, offer potential pathways for addressing remaining challenges in spatial proteomics. \nRegister NowBio\nMalte Kuehl studied medicine at the University of Hamburg\, where he joined the Institute of Medical Systems Biology and the III. Medical Department to begin his Doctor of Medicine degree. In 2023\, he joined the Complex Tissue Lab at Aarhus University\, led by Prof. Puelles\, as a postdoc. His primary research interests include spatial omics\, image analysis\, and agentic AI.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-scaling-multiplexed-protein-imaging-analysis-for-subcellular-resolution-pathology/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/10/TIA-Centre-Seminar-Series-–-Scaling-Multiplexed-Protein-Imaging-Analysis-for-Subcellular-resolution-Pathology.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251110
DTEND;VALUE=DATE:20251112
DTSTAMP:20260827T213050
CREATED:20250527T083936Z
LAST-MODIFIED:20250624T130105Z
UID:100112972-1762732800-1762905599@www.pathologynews.com
SUMMARY:3rd Spatial Biology Congress: Asia
DESCRIPTION:0000Days00Hrs00Min00SecGlobal Engage is pleased to announce the 3rd Spatial Biology Congress Asia\, returning to Singapore on 5th and 6th November 2025. This prestigious event continues to serve as a hub for spatial biology experts from academia\, biotech companies\, and the pharmaceutical industry\, coming together to share cutting-edge insights and foster collaborations that push the boundaries of this rapidly evolving field. \nRun as single-track\, over 2-day\, this year’s edition will stage more than 15 top scientists presenting the latest discoveries in using spatial multi-omics tools to uncover molecular insights through the following sessions: \n\nSpatial genomics\, transcriptomics\, proteomics\, metabolomics\, and lipidomics\nComputational & data analysis integration\nSpatial profiling\nImage analysis\, AI and digital pathology for spatial\nSpatial biology in therapeutic areas\nSpatial omics in plant biology\n\nIf you are looking to stay at the forefront of spatial biology\, gain unparalleled insights from leading scientists\, and expand your professional network in this thriving field\, then this meeting is not to be missed. \nRegister NowWhy Attend?\n\n1\nConnect with researchers\, industry leaders\, and potential collaborators from across Asia and beyond. Networking can facilitate partnerships and foster collaborative projects that enhance your team’s research efforts. \n\n\n\n\n2\nGain access to cutting-edge research and developments in spatial biology\, including advancements in imaging technologies\, spatial transcriptomics\, and multi-omics approaches. \n\n\n\n\n3\nLearn from leading experts in the field through keynote presentations\, workshops\, and panel discussions that provide valuable insights into the applications of spatial biology in various research areas. \n\n\n\n\n4\nCross-Disciplinary Perspectives: Engage with professionals from diverse disciplines\, including molecular biology\, pathology\, and bioinformatics\, allowing your team to gain new perspectives and strategies for tackling complex biological questions. \n\n\n\n\n5\nExplore the latest tools and technologies available in the field of spatial biology. Understanding these innovations can help your team stay at the forefront of research and improve experimental outcomes. \n\n\n\n\n6\nStay updated on emerging trends and future directions in spatial biology\, helping your team align research goals with industry needs and advancements.
URL:https://www.pathologynews.com/event/3rd-spatial-biology-congress-asia/
LOCATION:Lee Kong Chian School of Medicine – NTU Singapore (Novena Campus)\, Singapore
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/3rd-Spatial-Biology-Congress-Asia.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251106
DTEND;VALUE=DATE:20251109
DTSTAMP:20260827T213050
CREATED:20251030T083754Z
LAST-MODIFIED:20251030T083754Z
UID:100116503-1762387200-1762646399@www.pathologynews.com
SUMMARY:DP-AI 9.0 2025
DESCRIPTION:0000Days00Hrs00Min00Sec\nFriday Sessions at Google Headquarters\, Chicago\, Illinois\nSaturday Lab Tours at Endeavor Health\, Evanston\, Illinois\n\nThe first day will feature presentations by local and international experts at Google Headquarters in Chicago\, IL. This is a unique opportunity for attendees to learn about Endeavor Health’s innovative approach to integrating digital pathology and AI into their laboratory systems alongside comparative use cases from other hospital systems across North America. \nOn the second day\, attendees will be shuttled to Endeavor Health in Evanston to tour multiple laboratory spaces\, following specimen collection\, processing\, and delivery to pathologist workstations and analysis. \nProgramming Themes:\n1) Institutional/Clinical Practice and Vendor Collaboration\n2) DICOM and its role in DP-AI\n3) Digitization\, Automation\, and DP-AI for building the AP Lab of the Future\n4) The Role of Foundation Models\, Generative AI/LLMs\, and Agentic AI in Pathology\, with a deep dive into the Current State of Regulatory Affairs in DP-AI \nRegister Now
URL:https://www.pathologynews.com/event/dp-ai-9-0-2025/
LOCATION:Google Headquarters\, Chicago\, Chicago\, IL\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/DP-AI-9.0-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251104
DTEND;VALUE=DATE:20251105
DTSTAMP:20260827T213050
CREATED:20251030T082713Z
LAST-MODIFIED:20251030T082713Z
UID:100116487-1762214400-1762300799@www.pathologynews.com
SUMMARY:UKNEQAS CPT Annual Participant Meeting 2025
DESCRIPTION:0000Days00Hrs00Min00SecFuture Innovations and Investments\nLeading The Future by Creating It\nThis event will centre on the future of Cellular Pathology\, exploring innovations\, technological advancements\, and the latest regulatory changes shaping the field. Key discussions will highlight how these developments impact laboratory operations and the workforce. In addition\, breakout sessions and Q&A opportunities with expert coordinators will provide practical insights into addressing everyday challenges faced in the field. \nRegister Now
URL:https://www.pathologynews.com/event/ukneqas-cpt-annual-participant-meeting-2025/
LOCATION:The Parkgate Hotel\, Cardiff\, Westgate Street\, Cardiff\, CF10 1DA\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/UKNEQAS-CPT-Annual-Participant-Meeting-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251104
DTEND;VALUE=DATE:20251105
DTSTAMP:20260827T213050
CREATED:20250513T103255Z
LAST-MODIFIED:20250530T140811Z
UID:100111937-1762214400-1762300799@www.pathologynews.com
SUMMARY:6th NHS Pathology Conference: Improving NHS diagnostics
DESCRIPTION:0000Days00Hrs00Min00SecClinical Diagnostics & Medical Sciences\nCurrent Landscape:\nPathology is increasingly becoming a collaborative and interdisciplinary field\, with a strong focus on integrating innovative technologies and practices. This shift is essential to meet the growing demands of modern healthcare\, where the challenges of disease management\, diagnostics\, and treatment require cutting-edge solutions and cross-border cooperation. \nTimeliness of Event:\nThis conference is especially relevant as healthcare systems face the dual pressures of managing current patient demands and integrating new technologies into pathology services. With the rapid evolution of healthcare needs and the advent of new diagnostic tools\, the event provides a timely platform for discussing how to optimize pathology services across regions and disciplines. \nRegister Now\n\n\n\n\n\n\n\nKey Subjects:\n\nPathology Beyond Borders: Integrating Innovation and Collaboration Across Disciplines: Exploring how international collaboration and innovative approaches are reshaping pathology\, breaking down silos\, and improving global health outcomes.\nMES Procurement Approach: A detailed discussion on the strategies and best practices for procuring Managed Equipment Services (MES)\, ensuring efficient and cost-effective delivery of pathology services.\nFire Panel Discussion: Cross-region Learnings: A dynamic exchange of insights from various regional pathology networks\, focusing on shared challenges and solutions\, operational strategies\, and enhancing cross-region collaboration.\nPathology 2.0: Pioneering Tech Advancements Shaping Future Services: Delving into the latest technological innovations such as AI\, digital pathology\, and next-generation sequencing that are revolutionising pathology services and setting the stage for the future.\nLocal Pathology Networks: Examining the role of local pathology networks in managing demand and capacity\, ensuring quality service delivery\, and optimising resource utilisation.\nManaging Demand and Capacity: Addressing the operational challenges in pathology\, including strategies for efficient demand management and capacity planning to meet the needs of modern healthcare.\n\nWhy Attend:\nAttendees will gain valuable insights into the future of pathology\, with a focus on integrating innovative technologies\, optimising procurement processes\, and enhancing cross-region collaboration. This event is an essential opportunity for professionals to learn from experts\, share best practices\, and explore new approaches to managing the growing complexities of pathology services.
URL:https://www.pathologynews.com/event/6th-nhs-pathology-conference-improving-nhs-diagnostics/
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/Birmingham-2025-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251028T153000
DTEND;TZID=UTC:20251028T163000
DTSTAMP:20260827T213050
CREATED:20250912T085339Z
LAST-MODIFIED:20250912T085339Z
UID:100115449-1761665400-1761669000@www.pathologynews.com
SUMMARY:ACCESS25 - The Future of Precision Medicine Starts at the Moment of Diagnosis
DESCRIPTION:0000Days00Hrs00Min00SecJoin Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision medicine — access to the right patients\, at the right moment\, with the right data. \nWith the launch of Proscia Aperture™\, biopharma leaders will discover how to automatically identify trial and treatment candidates at the moment of diagnosis—accelerating recruitment and advancing novel therapies. \nClinical lab leaders will learn how Aperture elevates the lab’s strategic role in the precision medicine ecosystem while creating new revenue streams. \nAnd for everyone attending\, the Partner Expo will feature breakthroughs in pathology AI\, next-generation infrastructure\, and enterprise solutions—delivered by the strongest ecosystem in the industry. \nRegister Now
URL:https://www.pathologynews.com/event/access25-the-future-of-precision-medicine-starts-at-the-moment-of-diagnosis/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/09/The-Future-of-Precision-Medicine-Starts-at-the-Moment-of-Diagnosis.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251027T140000
DTEND;TZID=Europe/London:20251027T150000
DTSTAMP:20260827T213050
CREATED:20251014T133819Z
LAST-MODIFIED:20251014T133819Z
UID:100116188-1761573600-1761577200@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series - Conformal Quantification of Predictive Uncertainty in Health AI
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Tapabrata (Rohan) Chakraborty from UCL\, London\, UK. \nAbstract\nFor AI to be trusted for use in high risk applications like healthcare\, it is important to ensure (AI Assurance) that the predictive uncertainty is within guaranteed bounds which can be achieved through conformal prediction based calibration at user defined level of significance. \nRegister NowBio\nRohan is a Theme/Group Lead in Frontier AI Assurance at the Alan Turing Institute and a Principal Research Fellow at UCL Cancer Institute. He leads TRAIL\, the Transparent and Responsible AI Lab shared between UCL/Turing. Rohan is an invited expert in Responsible AI with the Global Partnership on AI and an Editor with Springer Nature Computer Science. Rohan has a PhD in Computer Science and worked as a postdoctoral researcher at the University of Oxford where he continues to an Honorary Fellow of Linacre College and a Lecturer in Computer Science with Christ Church College.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-conformal-quantification-of-predictive-uncertainty-in-health-ai/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/10/TIA-Centre-Seminar-Series-Conformal-Quantification-of-Predictive-Uncertainty-in-Health-AI.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251023T160000
DTEND;TZID=Europe/London:20251023T170000
DTSTAMP:20260827T213050
CREATED:20251019T084830Z
LAST-MODIFIED:20251019T084830Z
UID:100116283-1761235200-1761238800@www.pathologynews.com
SUMMARY:AISight Dx Digital Pathology Platform: Live Deep Dive
DESCRIPTION:0000Days00Hrs00Min00SecJoin PathAI to learn how AISight Dx supports modern pathology workflows at enterprise scale. \nIn this webinar\, PathAI will show how AISight® Dx supports modern digital pathology workflows at scale\, including seamless slide management\, flexible collaboration\, and interoperability across a broad range of whole-slide imaging scanners\, and will explain what PCCP means for ongoing updates and customer value. \nYou’ll also see a live demonstration with case-based examples covering slide navigation\, AISight Live for synchronous and asynchronous collaboration\, annotation tools\, and the caselist dashboard. \nWhat you’ll learn\n\nWhat FDA 510(k) clearance with a PCCP means in practice for AISight Dx and your roadmap\nHow pathologists and lab leaders can standardize workflows\, collaborate across teams\, and stay ready for future feature updates enabled under the PCCP\nLive demo: lightning-fast slide navigation and manipulation\, measurements and annotations\, real-time and asynchronous collaboration with AISight Live\, case list triage\, search\, filters\, and workflow handoffs\n\nRegister Now
URL:https://www.pathologynews.com/event/aisight-dx-digital-pathology-platform-live-deep-dive/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/AISight-Dx-Digital-Pathology-Platform-Live-Deep-Dive.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251021T160000
DTEND;TZID=Europe/London:20251021T170000
DTSTAMP:20260827T213050
CREATED:20250827T154822Z
LAST-MODIFIED:20250827T154822Z
UID:100115293-1761062400-1761066000@www.pathologynews.com
SUMMARY:Multi-Omics Analysis Demonstrates Repetitive Head Impacts Induce Neuronal Loss and Neuroinflammation in Young Athletes
DESCRIPTION:0000Days00Hrs00Min00SecLearn how HALO image analysis is helping to advance the understanding of chronic traumatic encephalopathy!\nSummaryRepetitive head impacts (RHI) sustained from contact sports are the largest risk factor for chronic traumatic encephalopathy (CTE). Currently\, CTE can only be diagnosed after death and the multicellular cascade of events that trigger initial hyperphosphorylated tau (p-tau) deposition remain unclear. Further\, the symptoms endorsed by young individuals with early disease are not fully explained by the extent of p-tau deposition\, severely hampering development of therapeutic interventions. Using genomics\, spatial transcriptomics\, and histology it was observed that RHI exposure associates with a multicellular response in young individuals (<51 years old) prior to the onset of CTE p-tau pathology that correlates with number of years of RHI exposure. SPP1+ inflammatory microglia\, angiogenic and inflamed endothelial cell profiles\, reactive astrocytes\, and altered synaptic gene expression in excitatory and inhibitory neurons were identified in all individuals with exposure to RHI. Surprisingly\, elevation in collagen deposition around blood vessels that might be related to long term disease outcomes was also observed. Overall\, these results provide robust evidence that multiple years of RHI exposure is sufficient to induce lasting cellular alterations that may underlie p-tau deposition and help explain the early pathogenesis in young former contact sport athletes. \nLearning Objectives\nUnderstand how HALO image analysis can assist in characterizing pathology in neurodegenerative diseases \nUnderstand how HALO AI can be used to identify unique cell populations with complex\, varied shapes \nExplore how genomic data can be validated using histologic images analysis\n\nRegister NowPresenterJonathan Cherry\, PhD \nResearch Health Scientist \nVA Boston Healthcare System \nDirector\, Digital Pathology Core & Research Neuropathologist \nBoston University Alzheimer’s Disease Research Center and Boston University Chronic Traumatic Encephalopathy Center \nAssistant Professor of Pathology and Laboratory Medicine\nBoston University Avedisian & Chobanian School of Medicine \nDr. Cherry is an Assistant Professor of Pathology and Laboratory Medicine. He completed his undergraduate studies with a BS in biology at Ursinus College in 2008\, earned his doctoral degree in Pathology from the University of Rochester in 2015\, and joined the McKee laboratory as a postdoctoral researcher the same year. He was appointed as an assistant professor at Boston University School of Medicine in 2019. Dr. Cherry also holds a research health scientist position within the VA Boston Healthcare System. His laboratory space is located at the Jamaica Plain VA hospital where he performs his research and helps support the UNITE brain bank.  \nDr. Cherry’s research interests focus on understanding how neuroinflammation after repetitive traumatic brain injury contributes to CTE pathogenesis. Specifically\, Dr. Cherry seeks to identify what role microglia and inflammatory cytokines play in the early onset of hyperphosphorylated tau accumulation and spread.  \nDr. Cherry’s research also extends to histology analysis and machine learning. He is the director of the BU digital pathology core. This research entails exploring novel ways to analyze human postmortem tissue using machine learning algorithms for neuropathologic targets and better characterize pathology across a spectrum of neurodegenerative diseases including Alzheimer’s disease\, chronic traumatic encephalopathy\, frontotemporal lobar degeneration\, motor neuron diseases\, and others. 
URL:https://www.pathologynews.com/event/multi-omics-analysis-demonstrates-repetitive-head-impacts-induce-neuronal-loss-and-neuroinflammation-in-young-athletes/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/Multi-Omics-Analysis-Demonstrates-Repetitive-Head-Impacts-Induce-Neuronal-Loss-and-Neuroinflammation-in-Young-Athletes.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251020
DTEND;VALUE=DATE:20251022
DTSTAMP:20260827T213050
CREATED:20250624T132630Z
LAST-MODIFIED:20250731T142434Z
UID:100113792-1760918400-1761091199@www.pathologynews.com
SUMMARY:Conference on Artificial Intelligence in Medical Imaging
DESCRIPTION:0000Days00Hrs00Min00Sec\n\n\nCMIMI is now SIIM-CAIMI!\n\n\n\n\n\n\nNew name. Sharper focus. Same cutting-edge research.\n\n\n\n\n\nUnparalleled Research Focus\n\n\n\n\n\n\nIn-depth talks from top AI and imaging research centers with live Q&A\nA space to test ideas\, challenge norms\, and refine AI approaches\nAccepted abstracts published in the Supplement to the Journal of Imaging Informatics in Medicine\n\n\n\n\n\n\n\n\nImmersive Scientific Discussions\n\n\n\n\n\n\nDeep dives into methods\, results\, and clinical relevance\nDiscussions on AI bias\, model generalizability\, and regulatory considerations\nCase study-driven conversations connecting theory to real-world impact\n\n\n\n\n\n\n\n\n\n\nA Multidisciplinary Community\n\n\n\n\n\n\nConnect with researchers\, clinicians\, and industry leaders in an intimate setting\nBuild partnerships across academia and industry\nBe part of a welcoming environment for trainees and early-career professionals\n\n\n\n\n\n\n\n\n\n\n\n\nAI in Action – From Research to Real-World Applications\n\n\n\n\n\n\nCutting-edge model development for accuracy and explainability\nReal-world AI integration in imaging workflows\nEthics and regulation for responsible AI deployment\n\n\n\n\n\n\n\n\nRegister Now
URL:https://www.pathologynews.com/event/conference-on-artificial-intelligence-in-medical-imaging/
LOCATION:University of California\, Irvine\, CA\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/06/Conference-on-Artificial-Intelligence-in-Medical-Imaging.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251017
DTEND;VALUE=DATE:20251022
DTSTAMP:20260827T213050
CREATED:20250710T100115Z
LAST-MODIFIED:20250731T142312Z
UID:100114263-1760659200-1761091199@www.pathologynews.com
SUMMARY:ESMO Congress 2025
DESCRIPTION:0000Days00Hrs00Min00SecThe ESMO Congress is a highly influential global oncology platform for clinicians\, researchers\, patient advocates\, journalists and healthcare industry representatives from all over the world.\nESMO 2025 will be a place where groundbreaking discoveries\, cutting-edge treatments and a collaborative approach converge to shape the future of cancer care. \nYou will be able to learn from internationally renowned experts\, engage in thought-provoking discussions and connect with fellow oncology professionals that are driving advancements in diagnosis\, treatment and survivorship. \nA comprehensive educational and scientific programme will foster exchange and debate of translational cancer science\, showcase first announcements of potentially practice changing data and stimulate multidisciplinary discussions to improve treatment options for our patients. \nLearning objectives\n\nTo review and be updated on prevention\, screening and early diagnosis of cancer\nTo be updated on the latest breakthroughs in basic science\, translational and clinical cancer research\nTo analyze and understand the clinical perspective of the scientific advances in cancer biology\, diagnostics\, and new treatments\nTo learn the optimal roles of novel diagnostics and treatments for patients with cancer\n\nRegister NowMeet Our Partner\n\n\n\n\nMeet Mindpeak\, a pioneer in AI-powered pathology solutions helping labs accelerate cancer diagnostics with precision and efficiency. \nCatch them at ESMO 2025 — Booth #4010.  \nDiscover how AI is reshaping the future of oncology. \n\n\n\n\n\n\n\n\nAccreditation\nESMO-MORA: The Congress programme will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details . \nDisclaimer\nESMO is a scientific and professional\, non-political and non-religious organisation. ESMO will not accept responsibility for any comments or remarks made during any of our events by session chairs\, invited speakers\, presenters\, members or any other contributor\, formally or informally\, which might cause offence or be perceived as being biased. \nThe experts invited by ESMO as abstract Discussants are selected on an individual basis to provide their own interpretation of the data and are not acting as ESMO spokespersons. \nAll Speakers and Discussants are required to declare their interests\, if any\, and include a Declaration of Interest (DOI) slide at the start of their presentation(s). \nThe ESMO recommendations on the clinical utility of new drugs are only presented in the ESMO Clinical Practice Guidelines and such recommendations represent the only official position of ESMO.
URL:https://www.pathologynews.com/event/esmo-congress-2025/
LOCATION:Messe Berlin\, Messedamm 22\, Berlin\, 14055\, Germany
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/07/ESMO-Congress-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251016T160000
DTEND;TZID=Europe/London:20251016T170000
DTSTAMP:20260827T213050
CREATED:20250827T151754Z
LAST-MODIFIED:20250827T152303Z
UID:100115278-1760630400-1760634000@www.pathologynews.com
SUMMARY:Masterclass Webinar: Admin and Metadata Options in HALO Link
DESCRIPTION:0000Days00Hrs00Min00SecLearn how to maximize the efficiency\, customization\, and data management capabilities of your HALO Link deployments!\nSummaryJoin Indica Labs for this Masterclass Webinar designed for system administrators who want to maximize the efficiency\, customization\, and data management capabilities of their HALO Link deployments. This session will provide an in-depth review of the Admin Dashboard\, highlighting tools for managing users\, groups\, and permissions\, and explore the new Diagnostics Monitor tool for troubleshooting image viewing performance bottlenecks.  \n\nThe webinar will also dive into metadata management\, including how to create custom fields that support better data organization. Whether supporting a large research team or managing multi-site deployments\, this session will equip administrators with practical strategies to tailor HALO Link to their needs\, reduce administrative burden\, and empower users to work more efficiently. \n\nLearning Objectives\nLearn about all the functionality in the current Admin Dashboard in HALO Link \nLearn how the new opt-in Diagnostics Monitor feature (available in HALO Link 4.2) provides information for troubleshooting performance bottlenecks with image viewing \nLearn about tools to manage users\, permissions\, and user groups \nLearn about creating and managing system metadata fields  \n\nRegister NowPresentKat Latimer\nHALO Link Associate Product Manager\nIndica Labs  \nKat Latimer earned a ME in Biomedical Engineering from Colorado State University in 2025 and BS in Biochemistry from the University of New Mexico in 2018. Her graduate studies focused on tissue engineering and the use of biomaterials for wound healing. During her undergraduate studies\, Kat participated in several research opportunities including investigating the role of cellular adhesion proteins in HPV oncogene expression.  In 2020 she joined Indica Labs as a Software Quality Assurance Analyst. In 2021 she transitioned to the Product Management team and has since been promoted to the HALO Link Associate Product Manager role where she works closely with the software developers creating new features to improve the user experience. 
URL:https://www.pathologynews.com/event/masterclass-webinar-admin-and-metadata-options-in-halo-link/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/08/Masterclass-Webinar-Admin-and-Metadata-Options-in-HALO-Link.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251015T150000
DTEND;TZID=Europe/Paris:20251015T160000
DTSTAMP:20260827T213050
CREATED:20250902T135514Z
LAST-MODIFIED:20251013T141041Z
UID:100115332-1760540400-1760544000@www.pathologynews.com
SUMMARY:Spatially Resolved Transcriptomics and Graph-based Deep Learning Improve Accuracy of Routine CNS Tumor Diagnostics
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 3 PM CET\, 2 PM BST\, and 9 AM EST. \nSpatially resolved transcriptomics and graph-based deep learning are transforming how researchers approach and understand central nervous system (CNS) tumors. In this webinar we will deep dive into a publication that highlights how the NePSTA (neuropathology spatial transcriptomic analysis) framework combines advanced RNA sequencing technologies with neural network analyses to uncover detailed gene expression landscapes directly within tissue samples—even in complex or ambiguous cases. By mapping gene activity across individual tumor regions\, these tools reveal previously hidden molecular characteristics\, allow for more granular tissue classification\, and address challenges posed by compromised sample quality. \nLearning Objectives:\n\nUnderstand the challenges of conventional CNS tumor diagnostics and how spatial transcriptomics addresses them.\nLearn the basics of spatially resolved transcriptomics and how graph-based deep learning is applied in neuropathology.\nCompare spatial transcriptomics with traditional molecular techniques such as DNA methylation profiling and next-generation sequencing.\n\nRegister NowSpeaker:\nProf. Felix Sahm \nProf. Dr. Dr. med. Felix Sahm\, MBA is Vice-Chair of the Department of Neuropathology and Head of Molecular Neuropathology \nUniversity of Heidelberg \nAn internationally recognized expert in brain tumor diagnostics\, he has authored over 500 publications\, including landmark studies shaping the WHO classification of CNS tumors. His research focuses on integrating molecular and multi-omic approaches to improve precision diagnostics and patient care.
URL:https://www.pathologynews.com/event/spatially-resolved-transcriptomics-and-graph-based-deep-learning-improve-accuracy-of-routine-cns-tumor-diagnostics/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/09/GEN-WEB0-Featured-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251013T140000
DTEND;TZID=Europe/London:20251013T150000
DTSTAMP:20260827T213050
CREATED:20250929T163601Z
LAST-MODIFIED:20251003T080807Z
UID:100115844-1760364000-1760367600@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series - Towards Multimodal AI for Personalized Cancer Treatment
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThe next seminar will take place on Monday\, 13 October\, from 2–3 p.m. UK time. The Centre is delighted to announce that the session will feature Dr. Nadieh Khalili from Radboud UMC\, The Netherlands\, who will be joining online. \nAbstract\nThe integration of diverse data types—such as histopathology\, radiology\, and omics—offers a powerful opportunity to develop AI models that improve cancer diagnosis and treatment selection. In this talk\, I will present recent efforts from our group in developing and validating multimodal deep learning frameworks that predict treatment-relevant biomarkers directly from routine diagnostic images. I will highlight case studies in bladder and prostate cancer and discuss challenges related to data harmonization\, model generalization\, and clinical translation. \nRegister NowBio\nDr Nadieh Khalili is an Assistant Professor in AI at Radboud UMC\, where she leads research at the intersection of deep learning\, digital pathology\, and multi-modal data integration. Her work focuses on developing clinically meaningful AI tools for cancer diagnosis and treatment response prediction. She has a background in biomedical engineering and previously worked in R&D roles in industry. Dr Khalili is also actively involved in organizing scientific events and is a board member of the European Society of Digital Pathology.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-towards-multimodal-ai-for-personalized-cancer-treatment/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/09/TIA-Centre-Seminar-Series-Towards-Multimodal-AI-for-Personalized-Cancer-Treatment-.png
END:VEVENT
END:VCALENDAR